Sunshine Biopharma, Inc 4
4 · Sunshine Biopharma, Inc · Filed Apr 26, 2016
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Award
Common Stock
2016-04-22$0.01/sh+12,000,000$84,000→ 12,384,373 total - Purchase
Common Stock
2016-04-12$0.20/sh+253,082$50,009→ 30,570,776 total(indirect: Owned by Advanomics Corporation, an entity controlled by Reporting Person.)